Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Barrett's Esophagus Without Dysplasia · Barrett Oesophagitis With Dysplasia · Esophageal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands
Contact: Study coordinator (Wouter B Nagengast, Prof.) · w.b.nagengast@umcg.nl · +31(0)503615755

Study leads

Wouter B. Nagengast, Prof. dr.
Principal Investigator
University Medical Center Groningen

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

Barrett Esophagus · Barretts Esophagus With Dysplasia · Barrett's Esophagus Without Dysplasia

Abroad (travel likely)Recruiting

Scottsdale, United States · Jacksonville, United States